Measurement of Disposition Half‐Life, Clearance, and Residence Times

Michael Mayersohn1

1 The University of Arizona, Tucson, Arizona
Publication Name:  Current Protocols in Toxicology
Unit Number:  Unit 5.3
DOI:  10.1002/0471140856.tx0503s04
Online Posting Date:  May, 2001
GO TO THE FULL TEXT: PDF or HTML at Wiley Online Library

Abstract

This unit provides an overview of the principles underlying the elimination process. Experimental design issues, methods of data analysis, and complications that may be encountered are discussed. A complete worked example is provided to exemplify the methods of analysis that are available.

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Table of Contents

  • Aims and Objectives
  • Characterizing the Elimination/Disposition Process (Output)
  • Experimental Design Issues
  • Complicating Factors and Other Issues to Consider
  • Data Analysis: A Worked Example
  • Literature Cited
  • Figures
  • Tables
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Materials

GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Figures

Videos

Literature Cited

Literature Cited
   Beal, S.L. and Sheiner, L.B. 1992. NONMEM User's Guides. NONMEM Project Group, University of California, San Francisco.
   Benet, L.Z. and Galeazzi, R.L. 1979. Noncompartmental determination of the steady‐state volume of distribution. J. Pharm. Sci. 68:1071‐1074.
   Bolton, S. 1997. Pharmaceutical Statistics, 3rd ed., pp. 189‐210. Marcel Dekker, New York.
   Brown, J.E., Kitchell, B.B., Bjornsson, T.D., and Shand, D.D. 1981. The artifactual nature of heparin‐induced drug protein binding alterations. Clin. Pharmacol. Ther. 30:636‐643.
   Chindavijak, B., Belpaire, F.M., De Smet, F., and Bogaeert, M.G. 1988. Alterations of the pharmacokinetics and metabolism of propranolol and antipyrine elicited by indwelling catheters in the rat. J. Pharmacol. Exp. Ther. 246:1075‐1079.
   Claassen, V. 1994. Neglected factors in pharmacology and neuroscience research. In Techniques in the Behavioral and Neural Sciences, Vol. 12 (J.P. Huston, ed.) pp. 405‐414. Elsevier Science Publishing, New York.
   Dominguez, R., Goldblatt, H., and Pomerene, E. 1935. Kinetus of elimination of substances injected intravenously (experiments with creatinine). Amer. J. Physiol. 114:240‐254.
   Eichelbaum, M. and Gross, A.S. 1996. Stereochemical aspects of drug action and disposition. Adv. Drug Res. 28:1‐64.
   Ette, I.I., Kelman, A.W., Howie, C.A., and Whiting, B. 1994. Influence of inter‐animal variability on the estimation of population pharmacokinetic parameters in preclinical studies. Clin. Res. Regul. Affr. 11:121‐139.
   Fagin, K.D., Shinsako, J., and Dallman, M. 1983. Effects of housing and chronic cannulation on plasma ACTH and corticosterone in the rat. Am. J. Physiol. 245:E515‐E520.
   Gething, P.A. and Daley‐Yates, P.T. 1997. A sparse sampling, mixed effects approach to toxicokinetic analyses. Drug Info. J. 31:521‐527.
   Gumbleton, M. and Benet, L.Z. 1991. Drug metabolism and laboratory anesthetic protocols in the rat: Examination of antipyrine pharmacokinetics. Pharm. Res. 8:544‐546.
   Hulse, M., Feldman, S. and Bruckner, J.V. 1981. Effect of blood sampling schedules on protein drug binding in the rat. J. Pharmacol. Exp. Ther. 218:416‐420.
   Karol, M.D. 1989. Mean residence time and the meaning of AUMC/AUC. Biopharm. Drug Dispos. 11:179‐181.
   Kong, A.‐N. and Jusko, W.J. 1988. Definitions and applications of mean transit and residence times in reference to the two‐compartment mammillary plasma clearance model. J. Pharm. Sci. 77:157‐165.
   Kwan, K.C., Bohidar, N.R., and Hwang, S.S. 1984. Estimation of an effective half‐life. In Pharmacokinetics—A Modern View (L.Z. Benet, G. Levy, and B.L. Ferraiola, eds.) pp. 147‐162. Plenum Press, New York.
   Lassen, N.A. and Perl, W. 1979. Tracer Kinetic Methods in Medical Physiology, pp. 102‐112. Raven Press, New York.
   Levy, G. 1968. Dose dependent effects in pharmacokinetics. In Importance of Fundamental Principles in Drug Evaluation (D.H. Tedeschi and R.E. Tedeschi, eds.) pp. 141‐172. Raven Press, New York.
   Mahmood, I. 1997. A comparative computer simulation study of three different sparse‐sampling methods for the estimation of steady‐state area under the concentration‐time curve (AUC) and maximum concentration (Cmax) in toxicokinetics. J. Pharm. Sci. 86:579‐583.
   Manchee, G.R., Barrow, A., Kulkarni, S., Palmer, E., Oxford, J., Colthup, P.V., Maconochie, J.G. and Tarbit, M.H. 1993. Disposition of salmeterol xinafoate in laboratory animals and humans. Drug Metab. Dispos. 21:1022‐1028.
   Mayersohn, M. and Hamilton, R. 1993. The relationship between the terminal disposition half‐life and mean residence time in multicompartment models. Drug Metab. Dispos. 21:1172‐1173.
   Mayersohn, M. and Tannenbaum, S. 1998. On reclaiming data from the literature: Literature data “R and R” (recovery and reanalysis) with a commentary by G. Levy, using other people's data in publications. Am. J. Pharm. Ed. 62:363‐373.
   Mayersohn, M., Owens, S.M., Lopez Anaya, A., Bliss, M. and Achari, R. 1985. 4‐Methylpyrazole disposition in the dog: Evidence for saturable elimination. J. Pharm. Sci. 74:895‐896.
   McNamara, P.J., Fleishaker, J.C., and Hayden, T.L. 1987. Mean residence time in peripheral tissue. J. Pharmacokinet. Biopharm. 15:439‐450.
   Nedelman, J.R. and Gibiansky, E. 1996. The variance of a better AUC estimator for sparse, destructive sampling in toxicokinetics. J. Pharm. Sci. 85:884‐886.
   Nedelman, J.R., Gibiansky, E., Tse, F.L.S., and Babiuk, C. 1993. Assessing drug exposure in rodent toxicity studies without satellite animals. J. Pharmokinet. Biopharm. 21:323‐334.
   Perrier, D. and Mayersohn, M. 1982a. Noncompartmental determination of the steady‐state volume of distribution for any mode of administration. J. Pharm. Sci. 71:372‐373.
   Perrier, D. and Mayersohn, M. 1982b. Noncompartmental determination of the steady‐state volume of distribution for any mode of administration [erratum]. J. Pharm. Sci. 71:1427.
   Riegelman, S. and Collier, P. 1980. The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time. J Pharmacokinet. Biopharm. 8:509‐534.
   Rowland, M. and Tozer, T.N. 1995a. Clinical Pharmacokinetics—Concepts and Applications, 3rd ed. pp. 158‐181. Williams and Wilkins, Baltimore.
   Rowland, M. and Tozer, T.N. 1995b. Clinical Pharmacokinetics—Concepts and Applications, 3rd ed. pp. 160, 502‐503. Williams and Wilkins, Baltimore.
   Rowland, M. and Tozer, T.N. 1995c. Clinical Pharmacokinetics—Concepts and Applications, 3rd ed. pp. 394‐418. Williams and Wilkins, Baltimore.
   Sinha, V., Brendel, K., and Mayersohn, M. 2000. A simplified isolated perfused rat liver apparatus: Characterization and measurement of extraction ratios of selected compounds. Life Sci. 66:1795‐1804.
   Sukbuntherng, J., Hutchaleelaha, A., Martin, D.K., Pak, Y., and Mayersohn, M. Cocaine disposition kinetics and absorption in the rat: Influence of dose and route of administration. Submitted for publication.
   Tanigawara, Y., Yano, I., Kawakutsa, K., Nishimura, K., Yasuhara, M., and Hori, R. 1994. Predictive performance of the Bayesian analysis: Effects of blood sampling time, population parameters, and pharmacostatistical model. J. Pharmacokinet. Biopharm. 22:59‐71.
   Terao, N. and Shen, D.D. 1983. Alterations in serum protein binding and pharmacokinetics of l ‐propranolol in the rat elicited by the presence of an indwelling venous catheter. J. Pharmacol. Exp. Ther. 227:369‐375.
   Torres‐Molina, F., Aristorena, J.‐C., Garcia‐Carbonell, C., Granero, L., Chesa‐Jimenez, J., Pla‐Delfina, J., and Peris‐Ribera, J.‐E. 1992. Influence of permanent cannulation of the jugular vein on pharmacokinetics of amoxycillin and antipyrine in the rat. Pharm. Res. 9:1587‐1591.
   Tse, F.L.S. and Jaffe, J.M. 1991. Preclinical Drug Disposition—A Laboratory Handbook, pp. 47‐53. Marcel Dekker, New York.
   Tse, F.L. and Nedelman. 1996. Serial versus sparse sampling in toxicokinetic studies. Pharm. Res. 13:1105‐1108.
   Tse, F.L.S., Nickerson, D.F. and Aun, R. 1992. Effect of isoflurane anesthesia on antipyrine pharmacokinetics in the rat. Pharm. Res. 9:1515‐1517.
   Tsukamoto, H., Reidelberger, R.D., French, S.W. and Largman, C. 1984. Long‐term cannulation model for blood sampling and intragastric infusion in the rat. Am. J. Physiol. 247:R595‐R599.
   Tucker, G.T. and Lennard, M.S. 1990. Enantiomer‐specific pharmacokinetics. Pharmacol. Ther. 45:309‐329.
   Van Bree, J., Nedelman, J., Steimer, J.‐L., Tse, F., Robinson, W., and Niederberger, W. 1994. Application of sparse sampling approaches in rodent toxicokinetics: A prospective view. Drug Info. J. 28:263‐279.
   Veng‐Pedersen, P. 1986. A simple method for obtaining the mean residence time of metabolites in the body. J. Pharm. Sci. 75:818‐820.
   Wilkinson, G.R. 1987. Clearance approaches in pharmacology. Pharmacol. Rev. 39:1‐47.
   Wilkinson, G.R. and Shand, D.G. 1975. A physiological approach to hepatic drug clearance. Clin. Pharmacol. Ther. 18:377‐390.
   Yoburn, B.C., Morales, R., and Inturrisi, C.E. 1984. Chronic vascular catheterization in the rat: Comparison of three techniques. Physiol. Behav. 33:89‐94.
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library